The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.75
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.50 (5.882%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 8.75
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Innovative Eyewear Patent Applications

11 Jan 2024 07:00

RNS Number : 3203Z
Tekcapital plc
11 January 2024
 

11 January 2024

Tekcapital Plc

("Tekcapital")

Innovative Eyewear, Inc. Receives Notice of Allowance

for Fourteen Patent Applications

 

Tekcapital Plc (AIM: TEK), the UK intellectual property investment group announces that Innovative Eyewear, Inc. ("Innovative Eyewear") (NASDAQ: LUCY; LUCYW), the developer of ChatGPT enabled smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, is pleased to announce it has received Notices of Allowance from the United States Patent and Trademark in fourteen design patent applications protecting Innovative Eyewear's Lucyd Lyte eyewear designs. Receipt of a Notice of Allowance indicates that claims in the patent applications are patentable, and Innovative Eyewear expects the patents to be issued after payment of the issue fees. These design patents are directed to Innovative Eyewear's front plate and temple designs.

 

Harrison Gross, CEO of Innovative Eyewear Inc., commented:

 "We are thrilled to receive these additional Notices of Allowance. This underscores our mission to upgrade the world's eyewear whilst developing a strong intellectual property position to protect our unique smart eyewear designs and innovations, which now includes 109 licensed and owned patents including 20 patent applications."

 

The Company's products include the world's first smart eyewear powered with ChatGPT, which enables a wearer to speak any query to ChatGPT handsfree and hear the response through the glasses.

 

About Innovative Eyewear Inc.

Innovative Eyewear is a developer of cutting-edge ChatGPT enabled smart eyewear, under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands. True to our mission to Upgrade Your Eyewear®, our Bluetooth audio glasses allow users to stay safely and ergonomically connected to their digital lives and are offered in hundreds of frame and lens combinations to meet the needs of the optical market. To learn more and explore our continuously evolving collection of smart eyewear, please visit www.lucyd.co.

 

Tekcapital currently owns 5,189,086 shares of Innovative Eyewear, Inc. (approximately 40%).

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com.

 

Forward-Looking Statements

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving Innovative Eyewear, Inc., Lucyd or Tekcapital that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of Tekcapital, Innovative Eyewear Inc. or Lucyd's management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Innovative Eyewear Inc., Lucyd and/or Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Other than as required by relevant regulation or law, neither Innovative Eyewear Inc, Lucyd nor Tekcapital intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAQKKBQDBKBQDD
Date   Source Headline
22nd Aug 20227:00 amRNSNotification of Investor Webinar
18th Aug 20227:00 amRNSLucyd Portfolio Company Update
18th Aug 20227:00 amRNSInnovative Eyewear Inc. Closing of US $ 7.35 M IPO
15th Aug 20227:00 amRNSLucyd -Pricing of US$ 7.35 Million IPO
29th Jul 20224:41 pmRNSSecond Price Monitoring Extn
29th Jul 20224:35 pmRNSPrice Monitoring Extension
28th Jul 20227:00 amRNSHalf Year Report for period ending 31 May 2022
21st Jul 20224:40 pmRNSSecond Price Monitoring Extn
21st Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20224:41 pmRNSSecond Price Monitoring Extn
4th Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20227:00 amRNSSalarius First U.S.A. Bulk B2B Order
16th Jun 20229:55 amRNSGrant of Share Options
15th Jun 20222:42 pmRNSNotification of Major Holdings
7th Jun 20227:00 amRNSNotification of Major Holdings
1st Jun 20223:08 pmRNSNotification of Major Holdings
31st May 20222:30 pmRNSResult of AGM
30th May 20227:00 amRNSPortfolio Company Update :Salarius
25th May 20221:19 pmRNSTR-1: Notification of major holdings
25th May 20227:00 amRNSPlacing to Raise £2 Million (c.US$ 2.5M)
6th May 202211:36 amRNSNotice of AGM
6th May 20227:00 amRNSFinal Year End Record Results
5th May 20227:00 amRNSGuident Update
3rd May 20228:35 amRNSGuident Update
19th Apr 20227:00 amRNSPortfolio Company Update - Guident
1st Apr 20227:00 amRNSPortfolio Company Update - Salarius
25th Mar 202211:39 amRNSNotification of Major Holdings
7th Mar 202211:05 amRNSSecond Price Monitoring Extn
7th Mar 202211:00 amRNSPrice Monitoring Extension
14th Feb 20227:00 amRNSSalarius Update
11th Feb 20225:58 pmRNSExercise of Stock Options and Total Voting Rights
11th Feb 20222:06 pmRNSSecond Price Monitoring Extn
11th Feb 20222:00 pmRNSPrice Monitoring Extension
11th Feb 202211:06 amRNSSecond Price Monitoring Extn
11th Feb 202211:01 amRNSPrice Monitoring Extension
4th Feb 20227:00 amRNSGuident Update
2nd Feb 20227:00 amRNSLucyd Expands Ecommerce Channels
4th Jan 20227:00 amRNSSalarius Completes Oversubscribed Crowdfund
29th Dec 20217:00 amRNSSalarius Appoints CEO
24th Dec 20217:00 amRNSSalarius Appoints Non Executive Director
14th Dec 20217:00 amRNSLucyd Filing for United States IPO
9th Dec 20217:00 amRNSSalarius Update
22nd Nov 202112:09 pmRNSHolding(s) in Company
16th Nov 20217:00 amRNSSalarius Update
15th Nov 20217:00 amRNSSalarius Update
11th Nov 20217:00 amRNSAppointment of new Auditor
4th Nov 20217:00 amRNSPortfolio Company Update: Lucyd Ltd ("Lucyd")
3rd Nov 20217:00 amRNSPlacing to raise £3.0 million
27th Oct 20217:00 amRNSSalarius Appointment of Chief Medical Officer
26th Oct 20214:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.